StockNews.com Begins Coverage on Ekso Bionics (NASDAQ:EKSO)

Equities researchers at StockNews.com assumed coverage on shares of Ekso Bionics (NASDAQ:EKSO) in a note issued to investors on Friday. The firm set a “hold” rating on the stock.

A number of other equities research analysts have also weighed in on the company. HC Wainwright cut their price objective on Ekso Bionics from $10.00 to $9.00 and set a “buy” rating on the stock in a research report on Tuesday, October 29th. Lake Street Capital cut their price target on shares of Ekso Bionics from $2.50 to $2.00 and set a “buy” rating on the stock in a report on Tuesday, October 29th.

Ekso Bionics Price Performance

Shares of NASDAQ EKSO opened at $0.57 on Friday. The company has a market cap of $12.47 million, a price-to-earnings ratio of -0.87 and a beta of 1.43. The company has a quick ratio of 2.14, a current ratio of 2.81 and a debt-to-equity ratio of 0.28. The firm’s fifty day moving average is $0.84 and its 200 day moving average is $1.02. Ekso Bionics has a 52 week low of $0.50 and a 52 week high of $3.13.

Ekso Bionics (NASDAQ:EKSO) last issued its quarterly earnings data on Monday, October 28th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.08) by ($0.02). Ekso Bionics had a negative net margin of 62.95% and a negative return on equity of 83.09%. The firm had revenue of $4.13 million for the quarter, compared to the consensus estimate of $6.00 million. During the same period last year, the company posted ($0.24) earnings per share. On average, equities research analysts expect that Ekso Bionics will post -0.48 earnings per share for the current year.

Ekso Bionics Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.